GS
VNDA icon

Gagnon Securities’s Vanda Pharmaceuticals VNDA Stock Holding History

Gagnon Securities’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,131
Closed -$325K – 96
2017
Q3 		$325K Hold
18,131
– – 0.12% 68
2017
Q2 		$296 Sell
18,131
-60
-0.3% -$865 0.08% 67
2017
Q1 		$255K Sell
18,191
-208
-1% -$2.96K 0.11% 79
2016
Q4 		$293K Sell
18,399
-191
-1% -$3.07K 0.13% 76
2016
Q3 		$309K Sell
18,590
-22,307
-55% -$300K 0.13% 75
2016
Q2 		$458K Sell
40,897
-242
-0.6% -$2.34K 0.21% 56
2016
Q1 		$344K Hold
41,139
– – 0.16% 62
2015
Q4 		$383K Hold
41,139
– – 0.18% 55
2015
Q3 		$464K Sell
41,139
-22,149
-35% -$271K 0.23% 53
2015
Q2 		$803K Sell
63,288
-3,629
-5% -$39.1K 0.32% 46
2015
Q1 		$622K Buy
66,917
+550
+0.8% +$6.21K 0.21% 53
2014
Q4 		$950K Sell
66,367
-8,245
-11% -$97.6K 0.3% 38
2014
Q3 		$774K Sell
74,612
-17,826
-19% -$234K 0.26% 46
2014
Q2 		$1.5M Sell
92,438
-18,680
-17% -$249K 0.48% 30
2014
Q1 		$1.81M Sell
111,118
-23,158
-17% -$329K 0.54% 29
2013
Q4 		$1.67M Sell
134,276
-9,804
-7% -$98.5K 0.5% 32
2013
Q3 		$1.58M Sell
144,080
-7,085
-5% -$75.7K 0.49% 32
2013
Q2 		$1.22M Buy
+151,165
New +$1.02M 0.44% 31

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gagnon Securities's VNDA Position: Q4 2017 in Review

Gagnon Securities sold out of Vanda Pharmaceuticals (VNDA) in Q4 2017, closing a stake of 18,131 shares — an estimated $325K sold.

Gagnon Securities first reported a position in VNDA in Q2 2013 and held it in 18 quarters. The position peaked at $1.81M in Q1 2014. 125 funds tracked by Wall St. Rank hold VNDA as of Q4 2017.

  • Gagnon Securities reported no remaining Vanda Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Gagnon Securities sold 18,131 Vanda Pharmaceuticals shares in Q4 2017, an estimated $325K.
  • Gagnon Securities first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Gagnon Securities's Vanda Pharmaceuticals position peaked at $1.81M in Q1 2014.
  • 125 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2017.

Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.